NCT02398123

Brief Summary

The transversus abdominis plane (TAP) block is a relatively simple technique that provides myocutaneous anesthesia that, as part of a multimodal analgesic treatment, may be useful in the prevention and treatment of parietal postoperative pain. Initial experience with ultrasound TAP block demonstrated efficacy of the echo guided technique in different surgical procedures such as cesarean section, appendicectomy, laparoscopic cholecystectomy, infra umbilical surgery in adult and pediatric patients. Recently published clinical trials suggest that TAP block may represents an effective alternative to epidural anesthesia but further studies in larger population are necessary. Transversus-abdominis plane (TAP) block was found to increase analgesic consumption low thoracic-epidural analgesia (TEA) in ischemic heart disease patients after abdominal laparotomy (2). Others found comparable results between continuous transversus abdominis plane technique and epidural analgesia in regard to pain, analgesic use and satisfaction after abdominal surgery(3). The TAP block affords effective analgesia with opioid sparing effects, technical simplicity, and long duration of action. Some disadvantages include the need for bilateral block for midline incisions and absence of effectiveness for visceral pain (4). TAP block has been associated with good pain relief and decreased intraoperative and postoperative opioids requirements after laparoscopic surgery (5). The analgesic efficacy of the TAP block has been demonstrated in prospective randomized trials compared with placebo, in different surgical procedures such as abdominal surgery, hysterectomy, retro pubic prostatectomy, Caesarean section, laparoscopic cholecystectomy, and appendicectomy (6, 7, 8, 9, 5 and 10 respectively). All these studies have reported superiority of the TAP block in terms of reduction in visual analogue scale scores and morphine consumption. In this study the investigators try to compare Transversus Abdominis Plane (TAP) blocks versus caudal block for postoperative pain control after lower abdominal surgeries in pediatrics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Mar 2015

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

March 16, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 25, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

September 16, 2015

Status Verified

September 1, 2015

Enrollment Period

3 months

First QC Date

March 16, 2015

Last Update Submit

September 14, 2015

Conditions

Keywords

Transversus Abdominis Planecaudal blockpostoperative painchildren

Outcome Measures

Primary Outcomes (1)

  • Time for first analgesic request

    By investigators until hospital discharge, then through telephone interview with parents after that

    24 hours after surgery

Secondary Outcomes (4)

  • Total opioid consumption

    24 hours after surgery

  • Sedation level

    12 hours after surgery

  • Parent satisfaction scores

    24 hours after surgery

  • Modified Children's Hospital of Eastern Ontario Pain Scale (CHEOPS),

    2 h, 4 h, 6 h, 8 h, 10 h, 12 h, 18 h, 24 h after surgery

Study Arms (2)

Transversus abdominis plane block

ACTIVE COMPARATOR

Transversus Abdominis Plane block

Other: Transversus abdominis plane blockDrug: Bupivacaine

Caudal block

PLACEBO COMPARATOR

Caudal block

Other: Caudal blockDrug: Bupivacaine

Interventions

Children who received transversus aAbdominis plane block with 0.25% bupivacaine with epinephrine 1 mL/kg guided by ultrasound

Transversus abdominis plane block

Children who received caudal 0.25% bupivacaine 1 mL/kg

Caudal block
Caudal blockTransversus abdominis plane block

Eligibility Criteria

Age1 Year - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children
  • Lower abdominal surgery

You may not qualify if:

  • Allergy to study medications
  • Contraindications to caudal block
  • Contraindications to transversus abdominis block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, DK, 050, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Alaa Eldeeb, MD

    Associate Professor of Anesthesia and Surgical ICU, Mansoura University , Mansoura City, Egypt

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 16, 2015

First Posted

March 25, 2015

Study Start

March 1, 2015

Primary Completion

June 1, 2015

Study Completion

July 1, 2015

Last Updated

September 16, 2015

Record last verified: 2015-09

Locations